Funds and ETFs McKesson Corporation

Equities

MCK

US58155Q1031

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-06-07 pm EDT 5-day change 1st Jan Change
586.9 USD +0.13% Intraday chart for McKesson Corporation +3.04% +26.77%

ETFs positioned on McKesson Corporation

Name Weight AuM 1st Jan change Investor Rating
0.06% 324 M€ +6.59% -
0.06% 40 M€ +6.57% -
0.05% 1 M€ +3.03% -
0.05% 2 M€ +3.16% -
0.05% 753 M€ +0.97% -
0.04% 414 M€ +14.11% -
0.04% 1,006 M€ -.--% -
0.04% 18 M€ +3.81% -
0.04% 322 M€ +13.88% -
0.04% 29 M€ -.--% -
0.04% 104 M€ +4.15% -
0.03% 6 M€ +3.89%
0.03% 17 M€ +3.78% -
0.03% 163 M€ +0.31% -
0.03% 248 M€ +11.05% -
0.03% 284 M€ -.--%
0.02% 7 M€ +0.11% -
0.02% 13 M€ +17.94% -
0.02% 55 M€ +1.07% -
0.02% 8 M€ +1.54% -
0.01% 15 M€ -1.62% -
0.01% 114 M€ +4.36% -
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (87%); - distribution of medical and surgical products (4%); - other (1.6%): primarily technology services and software sales. The remaining net sales (7.4%) are from international activities.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
586.9 USD
Average target price
589.5 USD
Spread / Average Target
+0.45%
Consensus
  1. Stock Market
  2. Equities
  3. MCK Stock
  4. Funds and ETFs McKesson Corporation